ATE519751T1 - Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate - Google Patents

Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate

Info

Publication number: ATE519751T1
Authority: AT; Austria
Prior art keywords: dihydro; sulfonamide derivatives; sulfonamide; derivatives
Prior art date: 2007-04-19

Application number

AT08735983T

Other languages

English (en)

Inventor

Mcarthur Silvia Gatti

Juergen Wichmann

Thomas Johannes Woltering

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-19

Filing date

2008-04-09

Publication date

2011-08-15

2008-04-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2011-08-15 Application granted granted Critical

2011-08-15 Publication of ATE519751T1 publication Critical patent/ATE519751T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT08735983T 2007-04-19 2008-04-09 Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate ATE519751T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07106522		2007-04-19
PCT/EP2008/054257 WO2008128889A1 (en)	2007-04-19	2008-04-09	Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives

Publications (1)

Publication Number	Publication Date
ATE519751T1 true ATE519751T1 (de)	2011-08-15

Family

ID=39532268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08735983T ATE519751T1 (de)	2007-04-19	2008-04-09	Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate

Country Status (17)

Country	Link
US (1)	US7511033B2 (de)
EP (1)	EP2137167B1 (de)
JP (1)	JP2010524879A (de)
KR (1)	KR101151993B1 (de)
CN (1)	CN101657432B (de)
AR (1)	AR066086A1 (de)
AT (1)	ATE519751T1 (de)
AU (1)	AU2008240802B2 (de)
BR (1)	BRPI0810655A2 (de)
CA (1)	CA2684760A1 (de)
CL (1)	CL2008001083A1 (de)
ES (1)	ES2369866T3 (de)
IL (1)	IL201198A0 (de)
MX (1)	MX2009010729A (de)
PE (1)	PE20090148A1 (de)
TW (1)	TW200904448A (de)
WO (1)	WO2008128889A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012020820A1 (ja)	2010-08-11	2012-02-16	大正製薬株式会社	ヘテロアリール－ピラゾール誘導体
WO2013033246A2 (en)	2011-08-29	2013-03-07	Braincells, Inc.	Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
KR20160080799A (ko)	2014-12-30	2016-07-08	한국해양과학기술원	금 촉매를 이용한 α-피론 유도체 전합성 방법 및 이에 의해 합성되어 인간 암세포주에 세포독성을 가지는 α-피론 유도체
CN106243050B (zh) *	2016-08-10	2019-09-06	安徽恒星制药有限公司	一种适合工业化生产氯巴占的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6032775A (ja)	1983-07-30	1985-02-19	Daikin Ind Ltd	含フッ素ベンゾジアゼピン類
GB8601004D0 (en)	1986-01-16	1986-02-19	Fujisawa Pharmaceutical Co	1,5-benzodiazepine derivatives
GB9018601D0 (en)	1990-08-24	1990-10-10	Fujisawa Pharmaceutical Co	Tricyclic compounds
CA2054455A1 (en)	1990-11-23	1992-05-24	John James Delany	Substituted-2,3-dihydro-2-oxo-1,5-benzodiazepines and their use as fungicides
AU671477B2 (en)	1992-07-29	1996-08-29	Merck Sharp & Dohme Limited	Benzodiazepine derivatives
GB9314981D0 (en)	1993-07-20	1993-09-01	Glaxo Spa	Chemical compounds
AU3414295A (en)	1994-08-19	1996-03-14	Nps Pharmaceuticals, Inc.	Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases
WO1997005109A1 (en)	1995-07-31	1997-02-13	Novo Nordisk A/S	Heterocyclic compounds, their preparation and use
TR199800409T1 (xx)	1995-09-07	1998-05-21	F.Hoffmann-La Roche Ag	Kalp ve b�brek yetersizli�inin tedavii�in yeni 4-(oksialkoksifenil)-3-oksi-piperidinler
IL136250A0 (en)	1997-11-21	2001-05-20	Nps Pharma Inc	Metabotropic glutamate receptor antagonist compounds
WO2001010846A2 (en)	1999-08-05	2001-02-15	Igt Pharma Inc.	1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
ATE261945T1 (de)	1999-10-15	2004-04-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
ATE250039T1 (de) *	1999-10-15	2003-10-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
CA2442557C (en)	2001-04-12	2008-12-23	F. Hoffmann-La Roche Ag	Dihydro-benzo¬b\|¬1,4\|diazepin-2-one derivatives as mglur2 antagonists ii
NZ528345A (en)	2001-04-12	2005-04-29	F	Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I
US6949542B2 (en)	2002-02-06	2005-09-27	Hoffman-La Roche Inc.	Dihydro-benzo[b][1,4]diazepin-2-one derivatives

2008
- 2008-04-09 BR BRPI0810655-0A2A patent/BRPI0810655A2/pt not_active IP Right Cessation
- 2008-04-09 AU AU2008240802A patent/AU2008240802B2/en not_active Ceased
- 2008-04-09 MX MX2009010729A patent/MX2009010729A/es active IP Right Grant
- 2008-04-09 EP EP08735983A patent/EP2137167B1/de not_active Not-in-force
- 2008-04-09 WO PCT/EP2008/054257 patent/WO2008128889A1/en not_active Ceased
- 2008-04-09 KR KR1020097023810A patent/KR101151993B1/ko not_active Expired - Fee Related
- 2008-04-09 CA CA002684760A patent/CA2684760A1/en not_active Abandoned
- 2008-04-09 AT AT08735983T patent/ATE519751T1/de active
- 2008-04-09 CN CN2008800121352A patent/CN101657432B/zh not_active Expired - Fee Related
- 2008-04-09 JP JP2010503459A patent/JP2010524879A/ja not_active Ceased
- 2008-04-09 ES ES08735983T patent/ES2369866T3/es active Active
- 2008-04-14 US US12/102,140 patent/US7511033B2/en not_active Expired - Fee Related
- 2008-04-16 PE PE2008000663A patent/PE20090148A1/es not_active Application Discontinuation
- 2008-04-17 TW TW097114007A patent/TW200904448A/zh unknown
- 2008-04-17 AR ARP080101574A patent/AR066086A1/es unknown
- 2008-04-17 CL CL200801083A patent/CL2008001083A1/es unknown
2009
- 2009-09-24 IL IL201198A patent/IL201198A0/en unknown

Also Published As

Publication number	Publication date
CN101657432B (zh)	2013-04-10
US7511033B2 (en)	2009-03-31
BRPI0810655A2 (pt)	2014-11-04
IL201198A0 (en)	2010-05-17
ES2369866T3 (es)	2011-12-07
AR066086A1 (es)	2009-07-22
KR101151993B1 (ko)	2012-06-01
KR20100005715A (ko)	2010-01-15
CA2684760A1 (en)	2008-10-30
EP2137167A1 (de)	2009-12-30
AU2008240802A1 (en)	2008-10-30
CL2008001083A1 (es)	2008-10-24
CN101657432A (zh)	2010-02-24
US20080261957A1 (en)	2008-10-23
AU2008240802B2 (en)	2012-07-05
JP2010524879A (ja)	2010-07-22
MX2009010729A (es)	2009-10-26
PE20090148A1 (es)	2009-02-26
WO2008128889A1 (en)	2008-10-30
TW200904448A (en)	2009-02-01
EP2137167B1 (de)	2011-08-10

Publication	Publication Date	Title
HRP20151058T1 (xx)	2015-12-04	Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
ATE555107T1 (de)	2012-05-15	2-aza-bicyclo-ä2,2,1-üheptan-derivate
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
NO2021006I1 (no)	2021-02-15	Quofenix, delafloksacin
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
ATE513831T1 (de)	2011-07-15	Pyridinä3,4-büpyrazinone
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0811718A2 (pt)	2014-11-18	Derivados de 3,3-espiroindolinona
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
DE602008005634D1 (de)	2011-04-28	1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate
BRPI0907563A2 (pt)	2015-08-04	Derivados de 4,5-di-hidro-xazol-2-il amina
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
BRPI0813235A2 (pt)	2014-12-23	Combinação anti-helmíntica.
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
BRPI0816970A2 (pt)	2015-03-24	1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
DK2344471T3 (da)	2013-10-07	7-piperidinalkyl-3,4-dihydroquinolon-derivat
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
BRPI0917446A2 (pt)	2015-12-22	derivados de acilaminobenzamida.

Legal Events

Date	Code	Title	Description
2012-03-15	UEP	Publication of translation of european patent specification	Ref document number: 2137167 Country of ref document: EP

Date

Code

Title

Description

2012-03-15

UEP

Publication of translation of european patent specification

Ref document number: 2137167

Country of ref document: EP